Improving Medication Management for Inpatients with a Secondary Diagnosis of Parkinson Disease.


Journal

The American journal of nursing
ISSN: 1538-7488
Titre abrégé: Am J Nurs
Pays: United States
ID NLM: 0372646

Informations de publication

Date de publication:
01 May 2024
Historique:
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 25 4 2024
Statut: ppublish

Résumé

Patients who have Parkinson disease require individualized medication regimens to optimize care. A review of the medication management of patients admitted to a tertiary care hospital with a secondary diagnosis of Parkinson disease found significant departures from the patients' home regimen. Medication regimens are often altered by health care teams unfamiliar with Parkinson disease-specific care in order to conform to standard hospital medication orders and administration times, potentially resulting in increased patient falls, delirium, and mortality.A nurse-led multidisciplinary team consisting of pharmacy, nursing, informatics, neurology, and quality personnel implemented a quality improvement (QI) project between July 2020 and July 2022 to identify patients with Parkinson disease, including those with a secondary diagnosis and those undergoing deep brain stimulation, and customize medication management in order to reduce length of stay, mortality, falls, falls with harm, and 30-day readmissions. The QI project team also evaluated patient satisfaction with medication management.Among patients with a secondary diagnosis of Parkinson disease, the proportion who had medication histories conducted by a pharmacy staff member increased from a baseline of 53% to more than 75% per month. For all patients with Parkinson disease, those whose medication history was taken by a pharmacy staff member had orders matching their home regimen 89% of the time, whereas those who did not had orders matching the home regimen only 40% of the time. Among patients with a secondary diagnosis of Parkinson disease, the length-of-stay index decreased from a baseline of 1 to 0.94 and observed-to-expected mortality decreased from 1.03 to 0.78. The proportion of patients experiencing a fall decreased from an average of 5% to 4.08% per quarter, while the proportion of patients experiencing a fall with harm decreased from an average of 1% to 0.75% per quarter. The rate of 30-day readmissions decreased from 10.81% to 4.53% per quarter. Patient satisfaction scores were 1.95 points higher for patients who had medication histories taken by pharmacy than for those who did not (5 versus 3.05).

Identifiants

pubmed: 38661703
doi: 10.1097/01.NAJ.0001016384.47848.89
pii: 00000446-202405000-00025
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

50-57

Informations de copyright

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Références

Katz S, et al. Parkinson's disease is associated with increased complications, readmission rates, and costs of care after total hip arthroplasty: a matched-cohort analysis. The Journal of Hip Surgery 2020;4(3):149–54.
Cerri S, Blandini F. An update on the use of non-ergot dopamine agonists for the treatment of Parkinson's disease. Expert Opin Pharmacother 2020;21(18):2279–91.
Allen NE, et al. Recurrent falls in Parkinson's disease: a systematic review. Parkinsons Dis 2013;2013:906274.
GBD 2016 Parkinson's Disease Collaborators. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018;17(11):939–53.
Maserejian N, et al. Estimation of the 2020 global population of Parkinson's disease (PD) [abstract 198]. Mov Disord 2020;35(Suppl 1).
Azmi H, et al. Development of a Joint Commission disease-specific care certification program for Parkinson disease in an acute care hospital. J Neurosci Nurs 2019;51(6):313–9.
Chou KL, et al. Quality improvement in neurology: 2020 Parkinson disease quality measurement set update. Neurology 2021;97(5):239–45.
Hommel A, et al. The association of comorbidity with Parkinson's disease-related hospitalizations. Parkinsonism Relat Disord 2022;104:123–8.
Okunoye O, et al. Rate of hospitalizations and underlying reasons among people with Parkinson's disease: population-based cohort study in UK primary care. J Parkinsons Dis 2022;12(1):411–20.
Kwei K, Frucht S. Acute presentation of nonmotor symptoms in Parkinson's disease. Int Rev Neurobiol 2017;134:973–86.
Lertxundi U, et al. Medication errors in Parkinson's disease in patients in the Basque Country. Parkinsonism Relat Disord 2017;36:57–62.
Seppi K, et al. Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence-based medicine review. Mov Disord 2019;34(2):180–98.
Weintraub D, et al. Association of antipsychotic use with mortality risk in patients with Parkinson disease. JAMA Neurol 2016;73(5):535–41.
The Joint Commission. Disease-specific care certification review process guide. Oakbrook Terrace, IL; 2024 Jan. https://www.jointcommission.org/-/media/tjc/documents/accred-and-cert/survey-process-and-survey-activity-guide/2024/disease-specific-care-organization-rpg.pdf.
Fleenor LM, et al. Validation and evaluation of a prior-to-admission medication list discrepancy risk-scoring tool. J Am Coll Clin Pharm 2023;6(12):1321–29.

Auteurs

Arlene Boudreaux (A)

Arlene Boudreaux is a clinical nurse specialist at Vanderbilt University Medical Center, Nashville, TN, where Ryan F. Schell is a clinical pharmacy manager, Scott D. Nelson and Fenna Phibbs are associate professors, Jessica Stroh is a patient care coordinator, and Amanda Fraley Depp is a clinical pharmacist. Contact author: Arlene Boudreaux, arlene.boudreaux@yahoo.com. The authors have disclosed no potential conflicts of interest, financial or otherwise.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH